Big Gain For ORIC Pharmaceuticals, Inc.
Fri, Oct 08, 2021 at 05:33 PM
ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ) jumped higher at $15.46, a gain of 25.9%. On Thu, Oct 07, 2021, ORIC:NASDAQ hit a New 2-Week Low of $12.28. The stock got featured on our News Catalysts scanner on Thu, Oct 07, 2021 at 01:56 PM in the 'MISCELLANEOUS' category. From Thu, Sep 23, 2021, the stock recorded 10.00% Up Days and 18.18% Green Days
About ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ)
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101 and ORIC-533.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 95.97%
- DATS (DATS:NASDAQ), 45.77%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 44.53%
- Renren Inc. (RENN:NYSE), 44.46%
- HUDI (HUDI:NASDAQ), 36.27%
- ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ), 25.9%
- NXTP (NXTP:NASDAQ), 23.68%
- MITC (MITC:NASDAQ), 21.98%
- Altisource Portfolio Solutions S.A. (ASPS:NASDAQ), 21.19%
- Aehr Test Systems (AEHR:NASDAQ), 16.69%